(1)
Efficacy of Bosentan in the Treatment of Raynaud’s Phenomenon in Patients With Systemic Sclerosis Never Treated With Prostanoids. Reumatismo 2014, 65 (6), 286-291. https://doi.org/10.4081/reumatismo.2013.691.